Mackenzie Financial’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.92M Sell
143,571
-28,031
-16% -$1.52M 0.01% 570
2025
Q4
$8.44M Sell
171,602
-26,753
-13% -$1.25M 0.01% 535
2025
Q3
$8.56M Buy
198,355
+8,947
+5% +$349K 0.01% 528
2025
Q2
$7.27M Buy
189,408
+35,203
+23% +$1.35M 0.01% 534
2025
Q1
$5.97M Buy
+154,205
New +$5.65M 0.01% 543
2018
Q4
Sell
-22,037
Closed -$1.11M 1177
2018
Q3
$1.11M Sell
22,037
-104
-0.5% -$5.28K ﹤0.01% 742
2018
Q2
$1.12M Buy
22,141
+8,895
+67% +$448K ﹤0.01% 669
2018
Q1
$647K Buy
13,246
+2,092
+19% +$97.4K ﹤0.01% 694
2017
Q4
$495K Buy
11,154
+3,165
+40% +$146K ﹤0.01% 689
2017
Q3
$405K Buy
7,989
+460
+6% +$23.3K ﹤0.01% 537
2017
Q2
$406K Buy
7,529
+3,689
+96% +$197K ﹤0.01% 535
2017
Q1
$202K Buy
+3,840
New +$195K ﹤0.01% 606

Other funds holding GSK